每经AI快讯，中成股份（SZ 000151，收盘价：12.01元）12月29日晚间发布公告称，公司第九届第三十 二次董事会会议于2025年12月29日在北京市东城区安定门西滨河路9号中成集团大厦公司会议室召开。 每经头条（nbdtoutiao）——绕开光刻机"卡脖子"，中国新型芯片问世！专访北大孙仲：支撑AI训练和 具身智能，可在28纳米及以上成熟工艺量产 （记者 张明双） 2025年1至6月份，中成股份的营业收入构成为：成套设备进出口收入占比58.27%，复合材料生产占比 21.72%，环境科技占比19.87%，其他业务占比0.14%。 截至发稿，中成股份市值为41亿元。 ...

Group 1 - The core point of the article is that Zhongcheng Co., Ltd. (SZ 000151) held its 30th meeting of the 9th Board of Directors on October 24, 2025, to review the Q3 2025 report [1] - For the first half of 2025, the revenue composition of Zhongcheng Co., Ltd. was as follows: 58.27% from complete equipment import and export, 21.72% from composite materials production, 19.87% from environmental technology, and 0.14% from other businesses [1] - As of the report, Zhongcheng Co., Ltd. has a market capitalization of 4.3 billion yuan [1] Group 2 - The article mentions that Chinese innovative drugs have sold overseas licenses worth 80 billion USD this year [1] - It highlights a conversation with Lu Gang, a partner at Chuangdong Investment, discussing the hot secondary market for biomedicine while the primary market faces fundraising challenges [1]